Ameritas Investment Partners’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-170
| Closed | -$21K | – | 3238 |
|
|
2021
Q1 | $21K | Buy |
170
+39
| +30% | +$4.82K | ﹤0.01% | 2543 |
|
|
2020
Q4 | $15K | Hold |
131
| – | – | ﹤0.01% | 2626 |
|
|
2020
Q3 | $16K | Hold |
131
| – | – | ﹤0.01% | 2504 |
|
|
2020
Q2 | $16K | Buy |
131
+75
| +134% | +$9.16K | ﹤0.01% | 2478 |
|
|
2020
Q1 | $11K | Buy |
56
+48
| +600% | +$9.43K | ﹤0.01% | 2517 |
|
|
2019
Q4 | $3K | Hold |
8
| – | – | ﹤0.01% | 2955 |
|
|
2019
Q3 | $2K | Hold |
8
| – | – | ﹤0.01% | 3037 |
|
|
2019
Q2 | $3K | Hold |
8
| – | – | ﹤0.01% | 2999 |
|
|
2019
Q1 | $4K | Hold |
8
| – | – | ﹤0.01% | 2890 |
|
|
2018
Q4 | $2K | Hold |
8
| – | – | ﹤0.01% | 2962 |
|
|
2018
Q3 | $5K | Hold |
8
| – | – | ﹤0.01% | 2954 |
|
|
2018
Q2 | $4K | Hold |
8
| – | – | ﹤0.01% | 2958 |
|
|
2018
Q1 | $20K | Buy |
+8
| New | +$20K | ﹤0.01% | 2425 |
|